Alembic`s Generic Clindamycin Phosphate Receives Approval in the U.S.
Alembic Pharmaceuticals Limited appoints Manish Kejriwal as an Independent Director of the company for the period of five consecutive years effective from March 31, 2024.
Alembic Pharmaceuticals Ltd on Monday said it received tentative approval for generic Ribociclib tablets used in the treatment of breast cancer in the March quarter. The tentative approval by the US Food & Drug Administration (USFDA) was for Ribociclib tablets of strength 200 mg, Alembic Pharmaceuticals said in a regulatory filing.
USFDA conducts inspection at Alembic Pharmaceuticals` Panelav oncology formulation facility
Alembic`s Generic Bromfenac Receives Approval in the U.S.
Alembic`s Generic Fluorouracil Receives Approval in the U.S.
Manufacturing operations disrupted at Sikkim plant due to flash floods: Alembic Pharma
Enforcement Report - Week of August 23, 2023
Alembic and Aurobindo Pharma, the U.S. unit of India’s Aurobindo, issued voluntary recalls of products because of quality issues and manufacturing deficiencies, respectively.
Mumbai: Alembic Pharmaceuticals expects the US business to bounce back as it gears up for a busy launch schedule in FY24, which includes oncology and non-oncology injectables, derma, and ophthalmic products. Many of these launches will be coming from the new facilities that cleared US Food and Drug Administration (USFDA) inspections. Alembic is also looking at possibilities of taking advantage of drug shortages in the US.nnnRead more at:nhttps://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-aims-for-us-rebound-with-new-launches/articleshow/102753259.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst